Medical Equipment

Cardiac Biomarkers Market Outlook Highlighting Growth Drivers And Market Evolution

April 10, 2026April 10, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Cardiac Biomarkers Market Expected To Scale Between 2026 And 2030?

The cardiac biomarkers market size has experienced rapid expansion in recent years. It is projected to increase from $21.19 billion in 2025 to $24.22 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.3%. This historical growth can be ascribed to several factors, including the increasing incidence of cardiovascular diseases, the expansion of emergency cardiac care services, the rising adoption of laboratory diagnostics, the growing use of biomarker-based diagnosis, and improvements in immunoassay technologies.

The cardiac biomarkers market is projected to experience significant expansion in the coming years. It is forecast to achieve a valuation of $42.21 billion by 2030, growing at a compound annual growth rate (CAGR) of 14.9%. This anticipated growth during the forecast period is propelled by factors such as the increasing need for quick cardiac diagnostics, the rising embrace of decentralized testing models, the broadening of preventive cardiology screening, growing investments into advanced diagnostic platforms, and the expanding integration of digital health analytics. Prominent trends for this period encompass the increasing uptake of high-sensitivity troponin tests, the expanding utilization of point-of-care cardiac testing, a rising demand for rapid diagnostic kits, the development of multiplex cardiac biomarker panels, and an intensified focus on the early detection of cardiac risk.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10234&type=smp

Which Key Drivers Are Affecting The Cardiac Biomarkers Market Development?

The escalating healthcare expenditures are anticipated to propel the expansion of the cardiac biomarker market moving forward. These health expenditures refer to all costs associated with providing health services, family planning activities, nutrition programs, and emergency help with a focus on health. Allocating healthcare funds to cardiac biomarkers aims to enhance early detection, facilitate personalized treatment, and enable efficient resource allocation, potentially diminishing the overall costs linked to cardiovascular diseases. For instance, in May 2024, a report from the Office for National Statistics, a UK-based government department, revealed that total healthcare expenditure climbed by 5.6% in nominal terms from 2022 to 2023, a significant increase compared to the 0.9% growth observed in 2022. Thus, the increment in healthcare expenditures is driving the growth of the cardiac biomarker market.

How Is The Cardiac Biomarkers Market Categorized Across Its Segment Groups?

The cardiac biomarkers market covered in this report is segmented –

1) By Biomarker Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA)

2) By Location Of Testing: Point Of Care Testing, Laboratory Testing

3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications

4) By End User: Hospitals, Specialty Clinics

Subsegments:

1) By Creatine Kinase (CK-Mb): CK-Mb Test Kits, CK-Mb Diagnostic Panels

2) By Troponins: Troponin I Test Kits, Troponin T Test Kits, Troponin Diagnostic Panels

3) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

4) By Natriuretic Peptides (BNP And NT-proBNP): BNP Test Kits, NT-ProBNP Test Kits, Natriuretic Peptides Diagnostic Panels

5) By Ischemia Modified Albumin (IMA): IMA Test Kits, IMA Diagnostic Panels

What Trends Are Transforming The Cardiac Biomarkers Market?

Major companies operating in the cardiac biomarker markets are heavily focused on developing innovative assays to expand their product portfolios, aiming to improve patient outcomes and address unmet medical needs. These novel biomarker assays contribute significantly to advancements in cardiac diagnostics, enhancing accuracy and broadening diagnostic capabilities. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a China-based medical devices and solutions provider company, introduced two new cardiac biomarkers: high-sensitivity troponin I (hs-cTnI) and NT-proBNP. These recent additions further strengthen Mindray’s diverse range of cardiac biomarkers crucial for diagnosing and managing cardiovascular diseases (CVDs).

Which Firms Are Influencing Competition In The Cardiac Biomarkers Market?

Major companies operating in the cardiac biomarkers market are F. Hoffmann-La Roche AG, Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Bio-Rad Laboratories Inc, bioMérieux SA, QuidelOrtho Corporation, Randox Laboratories Ltd, Becton Dickinson and Company, Tosoh Corporation, PerkinElmer Inc, Grifols S.A., DiaSorin S.p.A., Sysmex Corporation, Lepu Medical Technology (Beijing) Co. Ltd, Mindray Bio-Medical Electronics Co. Ltd, Fujirebio Holdings Inc, Euroimmun AG, Beckman Coulter Inc, Trinity Biotech plc

Get The Full Cardiac Biomarkers Market Report:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report

Which Region Accounts For The Largest Portion Of The Cardiac Biomarkers Market?

North America was the largest region in the cardiac biomarkers market in 2025. The regions covered in the cardiac biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cardiac Biomarkers Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=10234&type=smp

Browse Through More Reports Similar to the Global Cardiac Biomarkers Market 2026, By The Business Research Company

Acoustic Insulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/acoustic-insulation-global-market-report

Automotive Acoustic Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-acoustic-materials-global-market-report

Automotive Acoustic Engineering Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/automotive-acoustic-engineering-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795